PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 20, 2016Journal of Clinical Oncology

Immunotherapy (IO) versus targeted therapy triage in endometrial adenocarcinoma (EA) by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA).

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAlessandro D. SantinKMKathleen N. MooreCGCamille C. Gunderson

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Santin et al. (2016) studied this question.

synapsesocial.com/papers/6a1e936fae66660099a40afdhttps://doi.org/10.1200/jco.2016.34.15_suppl.5591
View Full Paper
Ask AI
Bookmark
Share